Filmio Studios Unveils New Fan-Commitment Data Layer as Superfan Beta Reveals Early Greenlighting Signals 
Best SEO Software for Agencies: Tools Moving Services Are Using 
VyOS Networks Announces VyOS 1.4.4 LTS Release, Reinforcing the Universal Networking Platform for Hybrid Cloud and Edge FINOS Launches Open Regtech Initiative as It Receives Record High Number of Open Source Contributions
Deutsche Bank, JPMorgan, ING, Alliance for Innovative Regulation (AIR) Contribute as Foundation Achieves Highest Monthly…
Combat Sports Fans Can’t Get Enough Xtreme Fighting Championships Action After Historic Relaunch Event XFC 43; It’s Not Too Late to Enjoy on Demand
ATLANTA, GA / ACCESSWIRE / November 12, 2020 / If you missed the live broadcast…
Kidoz Inc. Announces Record Profitable Q3 2020 Results
ANGUILLA, BWI / ACCESSWIRE / November 12, 2020 / Kidoz Inc. (TSXV:KIDZ) (the “Company”), kid-tech…
CanaFarma Hemp Products Corp. Provides Update on Management Cease Trade Order
VANCOUVER, BC / ACCESSWIRE / November 12, 2020 / CanaFarma Hemp Products Corp. (CSE:CNFA) (the…
Kiadis announces presentations at the 2020 ASH Annual Meeting and Exposition
Amsterdam, The Netherlands, November 13, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext…
Innate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in Sézary Syndrome
Priority Medicines (PRIME) designation supports the potential for lacutamab to benefit Sézary Syndrome patients in…
ObsEva SA to present at Jefferies Virtual London Healthcare Conference, November 17 – 19, 2020
Geneva, Switzerland and Boston, MA – November 13, 2020 – ObsEva SA (NASDAQ: OBSV /…
INNATE PHARMA RECEIVES PRIME DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR LACUTAMAB IN SÉZARY SYNDROME
Priority Medicines (PRIME) designation supports the potential for lacutamab to benefit Sézary Syndrome patients in…
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
CANTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Keros Therapeutics Announces Pricing of Public Offering of Common Stock
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020
LA JOLLA, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
Aileron Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
Presented positive clinical proof-of-concept data from ongoing ALRN-6924 Phase 1b trial in patients with p53-mutated…
PLx Pharma Inc. 2020 Third Quarter Financial Results and Business Update Conference Call Rescheduled to November 16, 2020
SPARTA, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or…
Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
Highlights include closing $19.2 million public offering, uplisting to Nasdaq, and positive progress with multiple…
Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2020 Financial Results
WOODCLIFF LAKE, NJ, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Timber Pharmaceuticals, Inc….
Cassava Sciences Announces Proposed Public Offering of Common Stock
AUSTIN, Texas, Nov. 12, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”…
EXMceuticals Provides Bi-Weekly Default Status Report
VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2)…
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech & Diagnostics Forum
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Tonix Pharmaceuticals Outlines New Statistical Method to Analyze Future PTSD Studies at the 3rd Annual Neuropsychiatric Drug Development Summit
Increasing Placebo Responses in PTSD Drug Trials Raise Questions About Current Methods of Measuring or…
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader…